The effect of early Helicobacter pylori eradication on the healing of ESD-induced artificial ulcers
Open Access
- 1 May 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (22) , e15807
Abstract
Background: The role of Helicobacter pylori eradication is still not clear in endoscopic submucosal dissection (ESD)-induced artificial ulcer. This study investigates the therapeutic effects of H. pylori eradication on ESD-induced artificial ulcers. Methods: Eighty-four patients with ESD-induced artificial ulcers were enrolled. H. pylori eradication success subgroup (Group A1) and H. pylori eradication failure subgroups (Group A2) received standard triple therapy orally for 7 days, followed by esomeprazole 20 mg bis in die (bid) orally for the remainder of the treatment period (4 weeks in total). The H. pylori positive (Group B1) and H. pylori negative subgroups (Group B2) received esomeprazole 20 mg bid orally for 4 weeks. Ulcer healing was evaluated by gastroscopy, and H. pylori was identified by a C13 breath test or an Hp-RUT 2 and 6 months after treatment. Results: Successful eradication of H. pylori can promote healing of ESD-induced artificial ulcers. The ESD-induced artificial ulcer healing rate in Group A1 was statistically higher than that in Groups A2, B1, and B2. Conclusion: Our results indicated that early H. pylori eradication therapy can promote ESD-induced artificial ulcer healing in H. pylori positive patients with ESD-induced artificial ulcers.Keywords
This publication has 16 references indexed in Scilit:
- Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trialDigestive Endoscopy, 2015
- Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective studyBMC Research Notes, 2015
- Risk factors of delayed ulcer healing after gastric endoscopic submucosal dissectionSurgical Endoscopy, 2015
- Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter studyGastric Cancer, 2014
- Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patientsAlimentary Pharmacology & Therapeutics, 2014
- Risk factors for recurrence of artificial gastric ulcers after endoscopic submucosal dissectionEndoscopy, 2010
- Helicobacter pylori and Clinical Aspects of Gastric CancerHelicobacter, 2009
- Helicobacter pylori Eradication Therapy May Facilitate Gastric Ulcer Healing After Endoscopic Mucosal Resection: A Prospective Randomized StudyHelicobacter, 2008
- Helicobacter pylori status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissectionJournal of Gastroenterology and Hepatology, 2006
- The Effect of Helicobacter Pylori Eradication Therapy on Gastric Ulcer Healing After Endoscopic Mucosal ResectionJournal of Clinical Gastroenterology, 2006